Nephros Overview
Where could NEPH trade next? Consensus target price: $4.
Get informed when a big investor buys or sells
+ Follow$3.59
11.4% upside1 analysts in the last 4 months
High: $4 | Low: $4
No recommendations in the last 4 months.
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-17 | Northland Securities | $4 | 11.4% upside |  |
Nephros posts a target price of $4. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
A target price of $4 for NEPH means covering analysts, on average, see the stock 11.4% upside of $3.59 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.
Context for NEPH's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Nephros's other metric pages and overview cover the third.
Judging Nephros against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $4 here, then scan peer and history charts to see if the gap is persistent.
